EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Multicenter, randomised, single-blind, prospective study of azithromycin vs roxithromycin in the treatment of patients with lower respiratory tract infections



Multicenter, randomised, single-blind, prospective study of azithromycin vs roxithromycin in the treatment of patients with lower respiratory tract infections



Journal of Antimicrobial Chemotherapy 44(SUPPL A): 100, July




(PDF 0-2 workdays service: $29.90)

Accession: 035349982

Download citation: RISBibTeXText



Related references

A single-blind comparison of three-day azithromycin and ten-day co-amoxiclav treatment of acute lower respiratory tract infections. Journal Of Antimicrobial Chemotherapy. 31(suppl. E): 147-152, 1993

A single-blind, randomised, comparative study of clarithromycin and amoxycillin suspensions in the treatment of children with lower respiratory tract infections. Journal of ChemoTherapy 5(3): 174-180, 1993

Efficacy, safety and tolerability of azithromycin versus roxithromycin in the treatment of acute lower respiratory tract infections. Journal of Antimicrobial ChemoTherapy 37 Suppl C: 115-124, 1996

Clinical evaluation of oral levofloxacin 500 mg once-daily dosage for treatment of lower respiratory tract infections and urinary tract infections: a prospective multicenter study in China. Journal of Infection and ChemoTherapy 15(5): 301-311, 2010

An open comparative study of azithromycin and roxithromycin in the treatment of acute upper respiratory tract infections. Journal of Antimicrobial ChemoTherapy 37 Suppl C: 83-92, 1996

A prospective randomised parallel single-blind comparison of oral ciprofloxacin with oral co-trimoxazole in the treatment of respiratory tract infections in patients with chronic obstructive lung disease. Drug Investigation. 8(2): 110-117, 1994

Effectiveness of and tolerance to azithromycin versus roxithromycin in the treatment of patients with acute infections of the upper respiratory tract. La Clinica Terapeutica 144(1): 27-30, 1994

Roxithromycin as a five-day empiric treatment of respiratory tract infections A multicenter study. Neu, H C , Young, L S , Zinner, S H , Acar, J F Infectious Disease and Therapy; New macrolides, azalides, and streptogramins in clinical practice 418-421, 1995

Multicenter study of the clinical efficacy and tolerance of roxithromycin compared to erythromycin ethylsuccinate in lower respiratory tract infections. Pathologie-Biologie 36(5): 544-547, 1988

A randomized double-blind controlled trial of roxithromycin and cefaclor in the treatment of acute lower respiratory tract infections in general practice. Diagnostic Microbiology and Infectious Disease 15(4 Suppl): 97s-101s, 1992

Is roxithromycin better than amoxicillin in the treatment of acute lower respiratory tract infections in primary care? A double-blind randomized controlled trial. Journal of Family Practice 51(4): 329-336, 2002

Efficacy of roxithromycin in the treatment of lower respiratory tract infections in patients with chronic respiratory disease. Anales de Medicina Interna 8(6): 312-313, 1991

An open, multicentre, comparative study of the efficacy and safety of azithromycin and co-amoxiclav in the treatment of upper and lower respiratory tract infections in children. The Paediatric Azithromycin Study Group. Journal of International Medical Research 25(5): 285-295, 1997

Once-daily, 3-day azithromycin versus a three-times-daily, 10-day course of co-amoxiclav in the treatment of adults with lower respiratory tract infections: results of a randomized, double-blind comparative study. Journal of Antimicrobial ChemoTherapy 37 Suppl C: 93-101, 1996

Temafloxacin compared with ciprofloxacin in mild to moderate lower respiratory tract infections in ambulatory patients. A multicenter, double-blind, randomized study. Chest 100(6): 1497-1502, 1991